biosimilars
TS Picks: September 8, 2015
Jef Akst | Sep 8, 2015
Pharma edition
FDA OKs First Biosimilar
Tracy Vence | Mar 6, 2015
The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.
Pfizer to Acquire Hospira
Bob Grant | Feb 5, 2015
The pharmaceutical giant is purchasing the injectable drugmaker for about $15 billion.
Discover how to effectively purify biomolecules with chromatography
Streamlined Purification Workflows for Biomolecule Production
The Scientist Creative Services Team, Bio-Rad Laboratories | Mar 23, 2022
Researchers optimize chromatography-based workflows to purify biomolecules at scale.
Obamacare Will Affect Research
Bob Grant | Jun 29, 2012
The Supreme Court's decision to uphold President Barack Obama's health care reform law contains key provisions that will impact US science funding in the years to come.
Regulations for Biosimilars
Lisa A. Haile and Kimberly K. Egan | Jun 1, 2012
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?